Alwin Krämer

12.6k citations

124 papers · 5.9k indexed · 2 hit papers · h-index 39

Impact in

Cell Biology top 0.5%
- Microtubule and mitosis dynamics
Oncology top 1%
- Cancer-related Molecular Pathways

Papers in ⓘ

Hematology 53
- Acute Myeloid Leukemia Research 45
- Chronic Myeloid Leukemia Treatments 16
Cell Biology 39
- Microtubule and mitosis dynamics 38

Co-authors: Jiří Bártek (9 shared papers)Claudia Lukas (2 shared papers)Zuzana Hořejšı́ (1 shared paper)Per Guldberg (1 shared paper)Frederic Tort (1 shared paper)Maxwell Sehested (1 shared paper)Torben F. Ørntoft (1 shared paper)Karsten Zieger (1 shared paper)
Journals: Blood (19 papers)International Journal of Cancer (6 papers)Cell Cycle (6 papers)Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)
Partner nations: Germany United States Denmark

In The Last Decade

Alwin Krämer

119 papers receiving 5.8k citations

Hit Papers

align trajectories log scale

Tumour mutational burden: clinical utility, challenges and emerging improvements 2024 · 47 citations

Peers

Countries citing papers authored by Alwin Krämer

Since Specialization

Citations

This map shows the geographic impact of Alwin Krämer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alwin Krämer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alwin Krämer more than expected).

Fields of papers citing papers by Alwin Krämer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alwin Krämer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alwin Krämer. The network helps show where Alwin Krämer may publish in the future.

Co-authors

The 25 scholars most cited alongside Alwin Krämer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alwin Krämer Line = papers co-authored together Alwin Krämer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis Nature ·Jiřina Bártková, Zuzana Hořejšı́, Karen Koed, Alwin Krämer, Frederic Tort, Karsten Zieger, Per Guldberg, Maxwell Sehested, Jahn M. Nesland, Claudia Lukas, Torben F. Ørntoft, (unknown), Jiří Bártek Hit paper breakdown →	2005	2117
2	Centrosome-associated Chk1 prevents premature activation of cyclin-B–Cdk1 kinase Nature Cell Biology ·Alwin Krämer, Niels Mailand, Claudia Lukas, Randi G. Syljuåsen, Christopher J. Wilkinson, Erich A. Nigg, Jiří Bártek, (unknown)	2004	263
3	Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy Blood ·Hartmut Döhner, Michael Lübbert, Walter Fiedler, L Fouillard, A.K. Haaland, Joseph Brandwein, Stéphane Leprêtre, Oumédaly Reman, Pascal Turlure, Oliver G. Ottmann, Carsten Müller‐Tidow, Alwin Krämer, Emmanuel Raffoux, Konstanze Döhner, Richard F. Schlenk, Florian Voß, Tillmann Taube, Holger Fritsch, Johan Maertens	2014	187
4	STIL is required for centriole duplication in human cells Journal of Cell Science ·Julia Vulprecht, Ahuvit David, Alexandra Tibelius, Asher Castiel, Gleb Konotop, Fengying Liu, Felix Bestvater, Marc S. Raab, Hanswalter Zentgraf, Shai Izraeli, Alwin Krämer	2012	144
5	Proteins Required for Centrosome Clustering in Cancer Cells Science Translational Medicine ·Blanka Leber, Bettina Maier, Florian Fuchs, Jing Chi, Phillip Riffel, Simon Anderhub, Ludmila Wagner, Anthony D. Ho, Jeffrey L. Salisbury, Michael Boutros, Alwin Krämer	2010	143
6	Identification of Griseofulvin as an Inhibitor of Centrosomal Clustering in a Phenotype-Based Screen Cancer Research ·Blanka Rebacz, Thomas Ostenfeld Larsen, Mads H. Clausen, Mads H. Rønnest, H. Löffler, Anthony D. Ho, Alwin Krämer	2007	141
7	Requirement for CDK6 in MLL-rearranged acute myeloid leukemia Blood ·Theresa Placke, Katrin Faber, Atsushi Nonami, Sarah Putwain, Helmut R. Salih, Florian H. Heidel, Alwin Krämer, David E. Root, David A. Barbie, Andrei V. Krivtsov, Scott A. Armstrong, William C. Hahn, Brian J.P. Huntly, Stephen M. Sykes, Michael D. Milsom, Claudia Scholl, Stefan Fröhling	2014	126
8	Structure meets function—Centrosomes, genome maintenance and the DNA damage response Experimental Cell Research ·H. Löffler, (unknown), Jiří Bártek, Alwin Krämer	2006	87
9	Centrosome clustering and chromosomal (in)stability: A matter of life and death Molecular Oncology ·Alwin Krämer, Bettina Maier, Jiří Bártek	2011	87
10	Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1 The Journal of Cell Biology ·Alexandra Tibelius, Joachim Marhold, Hanswalter Zentgraf, Christoph E. Heilig, Heidemarie Neitzel, Bernard Ducommun, Anita Rauch, Anthony D. Ho, Jiří Bártek, Alwin Krämer	2009	74
11	Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity Biology of Blood and Marrow Transplantation ·Sascha Dietrich, Mindaugas Andrulis, Ute Hegenbart, Thomas Schmitt, Frauke Bellos, Uwe M. Martens, Julia Meißner, Alwin Krämer, Anthony D. Ho, Peter Dreger	2011	68
12	Cytarabine Dose of 36 g/m² Compared With 12 g/m² Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study Journal of Clinical Oncology ·Markus Schaich, Christoph Röllig, Silke Soucek, Michael Krämer, Christian Thiede, Brigitte Mohr, Uta Oelschlaegel, Norbert Schmitz, Reingard Stuhlmann, Hannes Wandt, Kerstin Schäfer‐Eckart, Walter E. Aulitzky, Martin Kaufmann, H. Bodenstein, J. Tischler, Anthony D. Ho, Alwin Krämer, Martin Bornhäuser, Johannes Schetelig, Gerhard Ehninger	2011	67
13	Checking Out the Centrosome Cell Cycle ·Alwin Krämer, (unknown), Jiří Bártek	2004	64
14	HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells Molecular Cancer Therapeutics ·Vianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, Anja Baumann, Nicola Giesen, Anikó Pálfí, Christoph Müller, Christian Lutz, Torsten Hechler, Michael Kulke, Carsten Müller‐Tidow, Alwin Krämer, Hartmut Goldschmidt, Andreas Pahl, Marc S. Raab	2020	61
15	Centrosome amplification in tumorigenesis Cancer Letters ·Simon Anderhub, Alwin Krämer, Bettina Maier	2012	61
16	Synthesis and Structure−Activity Relationship of Griseofulvin Analogues as Inhibitors of Centrosomal Clustering in Cancer Cells Journal of Medicinal Chemistry ·Mads H. Rønnest, Blanka Rebacz, Lene Markworth, Anette H. Terp, Thomas Ostenfeld Larsen, Alwin Krämer, Mads H. Clausen	2009	60
17	Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile Blood ·Kai Neben, Christian Giesecke, Silja Schweizer, Anthony D. Ho, Alwin Krämer	2002	59
18	EGF-Induced Centrosome Separation Promotes Mitotic Progression and Cell Survival Developmental Cell ·Balca R. Mardin, Mayumi Isokane, Marco Raffaele Cosenza, Alwin Krämer, Jan Ellenberg, Andrew M. Fry, (unknown)	2013	57
19	Centrosome aberrations in hematological malignancies Cell Biology International ·Alwin Krämer, Kai Neben, Anthony D. Ho	2005	57
20	DNA Damage-Induced Accumulation of Centrosomal Chk1 Contributes to its Checkpoint Function Cell Cycle ·H. Löffler, Tilmann Bochtler, Britta Fritz, Björn Tews, Anthony D. Ho, (unknown), Jiří Bártek, Alwin Krämer	2007	57

About Alwin Krämer

Alwin Krämer is a scholar working on Hematology, Cell Biology, Genetics, Oncology and Otorhinolaryngology, having authored 124 papers that have together received 5.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (45 papers), Microtubule and mitosis dynamics (38 papers), Cancer Diagnosis and Treatment (22 papers), Chronic Myeloid Leukemia Treatments (16 papers), DNA Repair Mechanisms (14 papers), Tumors and Oncological Cases (14 papers), Cancer-related Molecular Pathways (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). The work is most often cited by research in Cell Biology (1.8k citations), Oncology (2.2k citations), Hematology (835 citations), Molecular Biology (4.0k citations) and Cancer Research (814 citations). Alwin Krämer has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Jiří Bártek, Claudia Lukas, Zuzana Hořejšı́, Per Guldberg, Frederic Tort, Maxwell Sehested, Torben F. Ørntoft, Karsten Zieger, Jiřina Bártková and Jahn M. Nesland. Their work appears in journals such as Blood, International Journal of Cancer, Cell Cycle, Cancer Research and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact